Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Assessment of NPM1 Type a Mutation Burden By Digital Droplet PCR As a Marker of Minimal Residual Disease in Acute Myeloid Leukemia Patients Undergoing Stem Cell Transplantation

Juliane Grimm, Marius Bill, MDPhD, Laura Kloss, Madlen Jentzsch, MD, Maria Knyrim, Karoline Schubert, Christine Guenther, Vladan Vucinic, MD, Georg-Nikolaus Franke, MD, Wolfram Poenisch, MD, Michael Cross, PhD, Gerhard Behre, MD, Dietger Niederwieser, MD, Sebastian Schwind, MD

Blood (2015) 126 (23): 4398.

https://doi.org/10.1182/blood.V126.23.4398.4398

Published: 2015

Journal Articles

High Pri- Mir-181a-1 and Pri- Mir-181a-2 Expression Associates with Improved Outcomes in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation after Reduced Intensity Conditioning

Sebastian Schwind, MD, Madlen Jentzsch, MD, Marius Bill, PhD, Karoline Schubert, Laura Schmalbrock, Heike Weidner, Laura Kloss, Taqiuddine Gaber, Lynn Bonifacio, MD, Kathrin Wildenberger, Wolfram Pönisch, MD, Vladan Vucinic, MD, Georg-Nikolaus Franke, MD, Thoralf Lange, MD, Michael Cross, PhD, Gerhard Behre, MD, Dietger Niederwieser, MD

Blood (2014) 124 (21): 732.

https://doi.org/10.1182/blood.V124.21.732.732

Published: 2014

Journal Articles

Prognostic Implications of Pri-Mir-320a Expression in Acute Myeloid Leukemia Patients

Taqiuddine Gaber, Marius Bill, PhD, Madlen Jentzsch, MD, Karoline Schubert, Heike Weidner, Laura Kloss, Laura Schmalbrock, Bonifacio Lynn, MD, Kathrin Wildenberger, Wolfram Pönisch, MD, Vladan Vucinic, MD, Georg-Nikolaus Franke, MD, Thoralf Lange, MD, Michael Cross, PhD, Gerhard Behre, MD, Dietger Niederwieser, MD, Sebastian Schwind, MD

Blood (2014) 124 (21): 1037.

https://doi.org/10.1182/blood.V124.21.1037.1037

Published: 2014

Journal Articles

High Expression of Mir-9 down-Regulates the Poor Outcome Prognosticator ERG and Associates with Reduced Relapse-Rates in Acute Myeloid Leukemia

Heike Weidner, Marius Bill, PhD, Laura Schmalbrock, Madlen Jentzsch, MD, Laura Kloss, Taqiuddine Gaber, Lynn Bonifacio, MD, Karoline Schubert, Kathrin Wildenberger, Dennis Gerloff, Vladan Vucinic, MD, Georg-Nikolaus Franke, MD, Thoralf Lange, MD, Michael Cross, PhD, Stephan Fricke, MD, Gerhard Behre, MD, Dietger Niederwieser, MD, Sebastian Schwind, MD

Blood (2014) 124 (21): 1575.

https://doi.org/10.1182/blood.V124.21.1575.1575

Published: 2014

Journal Articles

Prognostic Significance Of EVI1 expression In Acute Myeloid Leukemia Patients With Intermediate and Adverse Cytogenetic Risk Undergoing Allogeneic Hematopoietic Cell Transplantation With Reduced-Intensity Conditioning

Marius Bill, PhD, Madlen Jentzsch, MD, Thoralf Lange, MD, Laura Kloss, Rainer Krahl, PhD, Georg Franke, MD, Stephan Fricke, MD, Vladan Vucinic, MD, Wolfram Poenisch, MD, Haifa Kathrin Al-Ali, MD, Gerhard Behre, MD, Michael Cross, PhD, Dietger Niederwieser, MD, Sebastian Schwind, MD

Blood (2013) 122 (21): 3383.

https://doi.org/10.1182/blood.V122.21.3383.3383

Published: 2013

NARROW

Assessment of NPM1 Type a Mutation Burden By Digital Droplet PCR As a Marker of Minimal Residual Disease in Acute Myeloid Leukemia Patients Undergoing Stem Cell Transplantation

High Pri- Mir-181a-1 and Pri- Mir-181a-2 Expression Associates with Improved Outcomes in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation after Reduced Intensity Conditioning

Prognostic Implications of Pri-Mir-320a Expression in Acute Myeloid Leukemia Patients

High Expression of Mir-9 down-Regulates the Poor Outcome Prognosticator ERG and Associates with Reduced Relapse-Rates in Acute Myeloid Leukemia

Prognostic Significance Of EVI1 expression In Acute Myeloid Leukemia Patients With Intermediate and Adverse Cytogenetic Risk Undergoing Allogeneic Hematopoietic Cell Transplantation With Reduced-Intensity Conditioning

Email alerts

ASH Publications

American Society of Hematology

Assessment of NPM1 Type a Mutation Burden By Digital Droplet PCR As a Marker of Minimal Residual Disease in Acute Myeloid Leukemia Patients Undergoing Stem Cell Transplantation

High Pri- Mir-181a-1 and Pri- Mir-181a-2 Expression Associates with Improved Outcomes in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation after Reduced Intensity Conditioning

Prognostic Implications of Pri-Mir-320a Expression in Acute Myeloid Leukemia Patients

High Expression of Mir-9 down-Regulates the Poor Outcome Prognosticator ERG and Associates with Reduced Relapse-Rates in Acute Myeloid Leukemia

Prognostic Significance Of EVI1 expression In Acute Myeloid Leukemia Patients With Intermediate and Adverse Cytogenetic Risk Undergoing Allogeneic Hematopoietic Cell Transplantation With Reduced-Intensity Conditioning

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only